Decision Maker Response

Jimmy Anderson’s response

Nov 25, 2019 — This past July, Senator Dave Hansen and I introduced legislation that would place a $100 cap on the monthly cost of insulin. With pharmaceutical companies tripling the cost of insulin, the need for state governments to step in to control the cost of this life-sustaining medication is obvious.

As many as 7.4 million Americans rely on insulin to survive. As of 2016, the monthly cost of insulin had risen to $450 and it is only climbing higher. Studies have found that one in four Americans are now rationing their doses or altogether skipping them because they cannot afford their prescribed amount. To continue to allow these pharmaceutical companies to put profit ahead of the health and safety of diabetic Americans cannot be tolerated.

In Wisconsin, roughly 10% of the adult population has diabetes and are struggling with medical expenses that are 2.3 times higher than for those who do not have diabetes. For diabetics, insulin is as necessary as food or water and to deny them access to this medication because it is unaffordable is immoral and unjustifiable.

Other states have already passed legislation to push back against this medical emergency. In May, Colorado capped the price of insulin at $100 per monthly copay. Wisconsin must be the next state to put a price cap on insulin and take this important step towards making insulin more affordable and accessible for all.